Comparison of pap test diagnoses and reflex high-risk HPV testing results before and after implementation of computerized ImagerAssisted screening

被引：0
|
作者：
Stumph, J. R. [1 ]
Schubert, P. L. [1 ]
Ely, K. A. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
373
引用
收藏
页码：85A / 86A
页数：2
相关论文
共 50 条
  • [41] Prior High Risk HPV Testing and Pap Test Results of 377 Invasive Cervical Cancers in China's Largest CAP Certified Laboratory
    Zheng, BaoWen
    Li, Zaibo
    Yan, Shanshan
    Chen, Congde
    Ding, Xiangdong
    Liang, Xiaoman
    Yang, Huaitao
    Zhao, Chengquan
    LABORATORY INVESTIGATION, 2015, 95 : 317A - 318A
  • [42] Prior High Risk HPV Testing and Pap Test Results of 377 Invasive Cervical Cancers in China's Largest CAP Certified Laboratory
    Zheng, Bao Wen
    Li, Zaibo
    Yan, Shanshan
    Chen, Congde
    Ding, Xiangdong
    Liang, Xiaoman
    Yang, Huaitao
    Zhao, Chengquan
    MODERN PATHOLOGY, 2015, 28 : 317A - 318A
  • [43] A comparison between immunocytochemical staining of pap tests with p16INK4A and high-risk HPV results:: A review of 70 cases
    O'Reilly, K
    Cohen, C
    Radhakrishnan, A
    Siddiqui, MT
    Nassar, A
    MODERN PATHOLOGY, 2006, 19 : 68A - 68A
  • [44] Performance evaluation of the Allplex HPV HR Detection assay in comparison with the Cobas HPV test for high-risk HPV genotyping
    Cho, Eun Hye
    Shin, Kangsu
    Park, Min-Seung
    Woo, Hee-Yeon
    Park, Hyosoon
    Kwon, Min - Jung
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (02)
  • [45] High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test
    Sun, Hongxia
    Masand, Ramya P.
    Patel, Shobhanaben Jagdishbhai
    Padmanabhan, Vijayalakshmi
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (11) : 908 - 913
  • [46] Frequency of Clinically Relevant Reflex Testing for HPV Type 16 and 18 on Invader® Platform in Routine High Risk HPV Screening
    Fulmer, John R.
    St John, Conan S.
    Vo, Stephen S.
    Mattison, Thomas R.
    Mattison, M. Trae
    Shappell, Scoff B.
    CANCER CYTOPATHOLOGY, 2008, 114 (05) : 376 - 377
  • [47] Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
    Vijayaraghavan, Arthi
    Efrusy, Molly
    Lindeque, Gerhard
    Dreyer, Greta
    Santas, Christopher
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : 377 - 383
  • [48] High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada
    Litwin, Charles
    Smith, Laurie
    Donken, Robine
    Krajden, Mel
    van Niekerk, Dirk
    Naus, Monika
    Cook, Darrel
    Albert, Arianne
    Ogilvie, Gina
    VACCINE, 2021, 39 (36) : 5198 - 5204
  • [49] Detection Rates for High Risk HPV DNA in Women 50 and Older with Negative and Abnormal Pap Test Results
    Zhao, Chengquan
    Austin, R. Marshall
    CANCER CYTOPATHOLOGY, 2008, 114 (05): : 366 - 367
  • [50] High-risk HPV platforms and test of cure: should specific HPV platforms more suited to screening in a 'test of cure' scenario be recommended?
    Innamaa, A.
    Dudding, N.
    Ellis, K.
    Crossley, J.
    Smith, J. H.
    Tidy, J. A.
    Palmer, J. E.
    CYTOPATHOLOGY, 2015, 26 (06) : 381 - 387
12345